by Garth Sundem | Jan 16, 2020 | Featured, Research
Patricia Ernst, PhD A massive research effort over more than a quarter century has tried to make personalized blood stem cells for use in treating leukemias, among many other uses. One way researchers have gone about this is to sample a patient’s adult cells and then...
by David Kelly | Jan 15, 2020 | Latest News, Research
Iñigo San Millán, PhD A byproduct of glucose called lactate, used by every cell in the body, may also prompt a mutated cell to become cancerous, according to new research from the University of Colorado Anschutz Medical Campus. The study was published Tuesday in...
by Garth Sundem | Jan 8, 2020 | Featured, Research
Tin Tin Su, PhD. (photo: Paul Muhlrad) The red, tube-shaped flowers of the firecracker bush (Bouvardia ternifolia), native to Mexico and the American Southwest, attract hummingbirds. The bush also provides the chemical bouvardin, which the lab of University of...
by Garth Sundem | Dec 4, 2019 | Featured, Research
Martin McCarter, MD, and colleagues target myeloid-derived suppressor cells in melanoma In melanoma, myeloid-derived suppressor cells (MDSCs) are bad – the more MDSCs, the poorer a patient’s prognosis. That’s because when these MDSCs expand to accumulate near melanoma...
by Garth Sundem | Dec 2, 2019 | Featured, Research
When prostate cancer spreads, it most often spreads to bone. And while the 5-year survival rate for prostate cancer that has not spread is nearly 100 percent, once the disease reaches bone, the 5-year survival rate is only 29 percent. Now a University of Colorado...
by Garth Sundem | Nov 19, 2019 | Featured, Research
Cathy J. Bradley, PhD Genetically targeted drugs and immunotherapies are transforming the way we treat many forms of lung cancer. However, a University of Colorado Cancer Center study published in the Journal of the National Cancer Institute shows that while the use...
